Materias dentro de su búsqueda.
Mostrando 24,021 - 24,040 Resultados de 24,879 Para Buscar '".eu"', tiempo de consulta: 0.47s Limitar resultados
  1. 24021
    “…The study included 282 adult patients (52% female; mean age 49 years) from the European multicentre consortium ENSAT-HT (www.ensat-ht.eu). Of these, 59 were diagnosed with PHT and 223 with EHT (40 CS, 107 PA and 76 PPGL). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SUN-LB97 Targeted Metabolomics as a Screening Tool in the Diagnosis of Endocrine Hypertension
  2. 24022
    “…METHODS: As part of the European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) study, we analysed a large multinational sample of First Episode Psychosis patients (FEP) and population controls, with available genotype and psychopathology information. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    S126. THE RELATION OF THE PSYCHOSIS CONTINUUM WITH SCHIZOPHRENIA POLYGENIC RISK SCORE AND CANNABIS USE
  3. 24023
    “…In this study we explore in a representative sample of people with psychosis from Kosovo*, as part of a large multi-country study (EU-funded IMPULSE project), whether demographic, socio-economic and clinical differences exist between male and female patients. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    T150. SEX DIFFERENCES IN PEOPLE WITH PSYCHOSIS: FINDINGS FROM A REPRESENTATIVE SAMPLE IN KOSOVO
  4. 24024
    “…The co-primary assessor-blinded outcomes when the infants are 18 months of age are as follows: (a) IgG geometric mean concentration (GMC) and proportion with IgG ≥100 EU/mL for protein D, and (b) IgG GMC and the proportion with IgG ≥0.35 µg/mL for pneumococcal serotypes 3, 6A and 19A. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial
  5. 24025
    por Barret, Didier
    Publicado 2020
    “…As the on-line travel footprint calculator may be used to all scientific collaborations and meetings, the calculator and its methodology described in this paper are made freely available to the science communitycommunity(https://travel-footprint-calculator.irap.omp.eu).…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Estimating, monitoring and minimizing the travel footprint associated with the development of the Athena X-ray Integral Field Unit: An on-line travel footprint calculator released to the science community
  6. 24026
    “…TRIAL REGISTRATION: www.clinicaltrialsregister.eu no.: 2018–002640-82. Prospectively registered November 20th. 2018. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment
  7. 24027
    “…REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02978040; URL: https://www.clinicaltrialsregister.eu; EudraCT 2017-001065-24.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial
  8. 24028
    “…Ertugliflozin, a selective inhibitor of sodium-glucose cotransporter 2 (SGLT2), is approved in the US, EU, and other regions for the treatment of adults with type 2 diabetes mellitus (T2DM). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
  9. 24029
    “…MAIN BODY: In the current manuscript, we build on the interdisciplinary experience of the European PhD Training Network BtRAIN (https://www.btrain-2020.eu/) where bioinformaticians and brain barriers researchers collaborated to analyze and establish RNA-Seq datasets on vertebrate brain barriers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Advancing brain barriers RNA sequencing: guidelines from experimental design to publication
  10. 24030
    “…RÉSULTATS: Avant la campagne, toutes les EHPAD avaient eu des cas confirmés de COVID avec un taux de sujets atteints de 21,75 % (67/308) parmi les résidents, 15,2 % (40/263) parmi le personnel. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Personnel asymptomatique pour le SARS-COV-2 en EHPAD : une source de contamination des résidents ?
  11. 24031
    “…TRIAL REGISTRATION: EUDRA-CT: 2015–004306-42; https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004306-42/SI, registered 17. 12. 2015.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Influence of adjunctive azithromycin on microbiological and clinical outcomes in periodontitis patients: 6-month results of randomized controlled clinical trial
  12. 24032
    “…Based on well-controlled trials in adults with mild-to-severe disease, fixed-dose combination calcipotriol 50 μg/g + betamethasone dipropionate 0.5 mg/g (Cal/BD) cutaneous foam has been approved (Enstilar®, LEO Pharma) in the USA and EU for the treatment of psoriasis vulgaris for up to 4 weeks in adults. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5–15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials
  13. 24033
    por Cassetta, Luca, Bruderek, Kirsten, Skrzeczynska-Moncznik, Joanna, Osiecka, Oktawia, Hu, Xiaoying, Rundgren, Ida Marie, Lin, Ang, Santegoets, Kim, Horzum, Utku, Godinho-Santos, Ana, Zelinskyy, Gennadiy, Garcia-Tellez, Thalia, Bjelica, Sunčica, Taciak, Bartłomiej, Kittang, Astrid Olsnes, Höing, Benedikt, Lang, Stephan, Dixon, Michael, Müller, Verena, Utikal, Jochen Sven, Karakoç, Derya, Yilmaz, Kerim Bora, Górka, Emilia, Bodnar, Lubomir, Anastasiou, Olympia Evdoxia, Bourgeois, Christine, Badura, Robert, Kapinska-Mrowiecka, Monika, Gotic, Mirjana, ter Laan, Mark, Kers-Rebel, Esther, Król, Magdalena, Santibañez, Juan Francisco, Müller-Trutwin, Michaela, Dittmer, Ulf, de Sousa, Ana Espada, Esendağlı, Güneş, Adema, Gosse, Loré, Karin, Ersvær, Elisabeth, Umansky, Viktor, Pollard, Jeffrey W, Cichy, Joanna, Brandau, Sven
    Publicado 2020
    “…To overcome this issue, we formed a network through the COST Action Mye-EUNITER (www.mye-euniter.eu) with the goal to standardize and facilitate the comparative analysis of human circulating MDSC in cancer, inflammation and infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation
  14. 24034
    “…METHODS: Electronic peer-reviewed databases were searched in November 2019 for studies on factors related to the participation of migrants in cervical cancer screening conducted in EU/EFTA countries, using comprehensive search expressions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Factors associated with cervical cancer screening participation among migrant women in Europe: a scoping review
  15. 24035
    “…Trial registration: State Institute of Drug Control (SUKL), URL: http://www.sukl.eu/modules/nps/index.php?h=study&a=detail&id=958&lang=2, registration number 1205090000.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis
  16. 24036
    “…FUNDING: : The French Health Ministry (PHRC-I-14-056), EU H2020 (grant #633413), and the Association pour la Recherche sur la SLA (ARSLA).…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial
  17. 24037
    “…PACE (Palliative Care for Older People) is a 1-year palliative care programme aiming at integrating general palliative care into day-to-day routines in LTCFs, throughout seven EU countries. METHODS: A cluster RCT was conducted. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Decreased costs and retained QoL due to the ‘PACE Steps to Success’ intervention in LTCFs: cost-effectiveness analysis of a randomized controlled trial
  18. 24038
    “…TRIAL REGISTRATION: https://eudract.ema.europa.eu no. 2015-000917-31 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00259-020-04766-2) contains supplementary material, which is available to authorized users.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [(68)Ga]Ga-DOTA-E-[c(RGDfK)](2) PET/CT
  19. 24039
    “…Onze patients (13 %) ont eu des cas contacts de COVID-19, deux cas (2,4 %) de COVID non sévères ont été diagnostiqués. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact du confinement lié au COVID-19 chez les adultes présentant un syndrome de Prader-Willi
  20. 24040
    “…The study forms part of an EU Horizon 2020 funded research project on AYCs aged 15–17 years old. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The awareness, visibility and support for young carers across Europe: a Delphi study
Herramientas de búsqueda: RSS